Skip to main content
Fig. 12 | BMC Cancer

Fig. 12

From: Novel γδ T cell-based prognostic signature to estimate risk and aid therapy in hepatocellular carcinoma

Fig. 12

The clinical significance of RFESD in HCC. FAM53B are upregulated in HCC samples based on TCGA datasetA and cell lines (B), and lower RFESD expression level was significantly correlated with improved prognosis (C). (D) Copy number of immune cells in HCC. E Correlation analysis of RFESD with infiltrating B cells, CD4 + T cells, CD8 + T cells, Macrophages, Neutrophils and Dendritic cells using TIMER. The association between the expression levels of RFESD with CD274 (F), PDCD1LG2 (G), CTLA4 (H), and PDCD1 (I) using TIMER

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us